1. Change in Patient‐Reported Symptom Control in Patients With Neuroendocrine Tumors Treated With Lanreotide Depot: 1188. (October 2017) Authors: Wolin, Edward M.; Lowenthal, Susan Pitman; Fisher, George A.; Liyanage, Nilani; Mirakhur, Beloo; Pommier, Rodney F.; Shaheen, Montaser; Vinik, Aaron I. Journal: American journal of gastroenterology Issue: Volume 112(2017)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Effect of Lanreotide Depot/Autogel on Urinary 5‐Hydroxyindoleacetic Acid and Plasma Chromogranin A Biomarkers in Nonfunctional Metastatic Enteropancreatic Neuroendocrine Tumors. (24th October 2018) Authors: Pavel, Marianne E.; Phan, Alexandria T.; Wolin, Edward M.; Mirakhur, Beloo; Liyanage, Nilani; Pitman Lowenthal, Susan; Fisher, George A.; Vinik, Aaron I. Journal: Oncologist Issue: Volume 24:Number 4(2019) Page Start: 463 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Efficacy of Lanreotide Autogel/Depot (LAN) vs Placebo (PBO) for Symptomatic Control of Carcinoid Syndrome (CS) in Neuroendocrine Tumor (NET) Patients from the ELECT Study: 1076. (October 2016) Authors: Wolin, Edward M.; Fisher, George A.; Kunz, Pamela L.; Liyanage, Nilani; Lowenthal, Susan Pitman; Mirakhur, Beloo; Pommier, Rodney F.; Shaheen, Montaser; Vinik, Aaron Journal: American journal of gastroenterology Issue: Volume 111(2016)Supplement Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Liposomal irinotecan and 5-fluorouracil/leucovorin in older patients with metastatic pancreatic cancer – A subgroup analysis of the pivotal NAPOLI-1 trial. Issue 3 (May 2019) Authors: Macarulla, Teresa; Blanc, Jean-Frédéric; Wang-Gillam, Andrea; Chen, Li-Tzong; Siveke, Jens T.; Mirakhur, Beloo; Chen, Jie; de Jong, Floris A. Journal: Journal of geriatric oncology Issue: Volume 10:Issue 3(2019) Page Start: 427 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Longer Term Efficacy of Lanreotide Autogel/Depot (LAN) for Symptomatic Treatment of Carcinoid Syndrome (CS) in Neuroendocrine Tumor (NET) Patients from the ELECT Open Label Study: 2016 ACG Presidential Poster Award: 1052. (October 2016) Authors: Fisher, George A.; Wolin, Edward M.; Kunz, Pamela L.; Liyanage, Nilani; Mirakhur, Beloo; Lowenthal, Susan Pitman; Pommier, Rodney F.; Shaheen, Montaser; Vinik, Aaron Journal: American journal of gastroenterology Issue: Volume 111(2016)Supplement Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. NAPOLI-1 phase 3 study of liposomal irinotecan in metastatic pancreatic cancer: Final overall survival analysis and characteristics of long-term survivors. (February 2019) Authors: Wang-Gillam, Andrea; Hubner, Richard A.; Siveke, Jens T.; Von Hoff, Daniel D.; Belanger, Bruce; de Jong, Floris A.; Mirakhur, Beloo; Chen, Li-Tzong Journal: European journal of cancer Issue: Volume 108(2019) Page Start: 78 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Novel Tumor Growth Rate Analysis in the Randomized CLARINET Study Establishes the Efficacy of Lanreotide Depot/Autogel 120 mg with Prolonged Administration in Indolent Neuroendocrine Tumors. (1st February 2021) Authors: Dromain, Clarisse; Loaiza‐Bonilla, Arturo; Mirakhur, Beloo; Beveridge, Thomas J.R.; Fojo, Antonio Tito Journal: Oncologist Issue: Volume 26:Number 4(2021) Page Start: e632 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Patient‐Reported Symptom Control of Diarrhea and Flushing in Patients with Neuroendocrine Tumors Treated with Lanreotide Depot/Autogel: Results from a Randomized, Placebo‐Controlled, Double‐Blind and 32‐Week Open‐Label Study. (16th October 2017) Authors: Fisher, George A.; Wolin, Edward M.; Liyanage, Nilani; Pitman Lowenthal, Susan; Mirakhur, Beloo; Pommier, Rodney F.; Shaheen, Montaser; Vinik, Aaron Journal: Oncologist Issue: Volume 23:Number 1(2018) Page Start: 16 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Treatment Patterns and Clinical Outcomes in Patients With Metastatic Gastroenteropancreatic Neuroendocrine Tumors Treated in the Community Practice Setting in the United States. Issue 2 (February 2018) Authors: Jiao, Xiaolong; Pulgar, Sonia; Boyd, Marley; Braiteh, Fadi; Mirakhur, Beloo; Pitman Lowenthal, Susan; Fox, Patricia; Frytak, Jennifer; Cox, David; Paulson, A. Scott Journal: Pancreas Issue: Volume 47:Issue 2(2018) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗